|
CDC7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.44889722021003E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.83509995877307E-09 |
| Normal-vs-Stage2 |
1.554460E-02 |
| Normal-vs-Stage3 |
2.07729999999184E-05 |
| Normal-vs-Stage4 |
1.086420E-02 |
| Stage1-vs-Stage2 |
9.305800E-01 |
| Stage1-vs-Stage3 |
4.175000E-01 |
| Stage1-vs-Stage4 |
2.681800E-01 |
| Stage2-vs-Stage3 |
5.830200E-01 |
| Stage2-vs-Stage4 |
3.008600E-01 |
| Stage3-vs-Stage4 |
3.711600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.73230035555628E-10 |
| Normal-vs-AfricanAmerican |
1.30570000034247E-07 |
| Normal-vs-Asian |
4.502500E-02 |
| Caucasian-vs-AfricanAmerican |
6.974400E-01 |
| Caucasian-vs-Asian |
3.158000E-01 |
| AfricanAmerican-vs-Asian |
4.419200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.10540038128693E-10 |
| Normal-vs-Female |
6.8543000164567E-09 |
| Male-vs-Female |
4.215800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.40419999978315E-07 |
| Normal-vs-Extreme_Weight |
4.77929995579274E-09 |
| Normal-vs-Obese |
2.30100000053746E-07 |
| Normal-vs-Extreme_Obese |
1.111760E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.082800E-01 |
| Normal_Weight-vs-Obese |
8.414600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.594400E-01 |
| Extreme_Weight-vs-Obese |
9.896800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.630400E-01 |
| Obese-vs-Extreme_Obese |
3.294600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.57209999999931E-05 |
| Normal-vs-Age(41-60Yrs) |
1.3111955965428E-11 |
| Normal-vs-Age(61-80Yrs) |
2.9052000027896E-08 |
| Normal-vs-Age(81-100Yrs) |
1.401850E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.532400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.376060E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.613100E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.568280E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.971800E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.807800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.17821333087431E-12 |
| Normal-VS-Type2 PRCC |
5.078200E-03 |
| Normal-VS-KIRP CIMP |
4.032500E-04 |
| Normal-VS-Unclassified PRCC |
4.59310000000546E-06 |
| Type1 PRCC-VS-Type2 PRCC |
3.25810000001425E-06 |
| Type1 PRCC-VS-KIRP CIMP |
2.817900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.235000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.32170000002974E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
2.131800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.521570E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.74739999999818E-05 |
| Normal-vs-N1 |
6.18419999999231E-05 |
| Normal-vs-N2 |
1.410010E-01 |
| N0-vs-N1 |
3.362100E-02 |
| N0-vs-N2 |
3.615000E-01 |
| N1-vs-N2 |
8.165600E-01 |
|
|
